Correlation Between Nuvectis Pharma and MAIA Biotechnology

Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nuvectis Pharma and MAIA Biotechnology, you can compare the effects of market volatilities on Nuvectis Pharma and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and MAIA Biotechnology.

Diversification Opportunities for Nuvectis Pharma and MAIA Biotechnology

0.26

Correlation Coefficient

Nuvectis Pharma  MAIA Biotechnology

Modest diversification

The 3 months correlation between Nuvectis and MAIA is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and MAIA Biotechnology go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and MAIA Biotechnology

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.7 times more return on investment than MAIA Biotechnology. However, Nuvectis Pharma is 1.7 times more volatile than MAIA Biotechnology. It trades about 0.0 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.06 per unit of risk. If you would invest  680.00  in Nuvectis Pharma on August 31, 2024 and sell it today you would lose (176.00) from holding Nuvectis Pharma or give up 25.88% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nuvectis Pharma  vs.  MAIA Biotechnology

Nuvectis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

MAIA Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Nuvectis Pharma and MAIA Biotechnology

The main advantage of trading using opposite Nuvectis Pharma and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.

The idea behind Nuvectis Pharma and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.